Pro Medicus Limited shares soar on blockbuster outlook

Pro Medicus Limited (ASX:PME) looks an attractive growth prospect.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Small-cap healthcare and technology business Pro Medicus Limited (ASX: PME) saw its shares surge 5.5% today after announcing a $3 million five-year contract with a German hospital operator.

Founder led with overseas exposure and the tailwinds of being a digital healthcare business this small-cap Melbourne-based company looks to tick the boxes as an outstanding growth prospect.

The cloud-based software Pro Medicus provides helps healthcare operators to improve the storage, sharing and administration of patient records collected in the course of providing healthcare services.

Moreover, those electronic records and medical images are only likely to soar in volume over time due to new technologies and higher standards of care, which puts Pro Medicus and its software in something of a growth sweet spot.

On a roll

The company's been winning big new contracts to prove the point and continues to grow in both private and public hospitals in the US and Europe.

The German contract win is for a public sector hospital and often once traction is gained within public healthcare sectors further success often materialises as a consequence of a market-leading reputation and the reversion to uniformity.

While public healthcare administrations globally have eye-wateringly huge budgets the private sector is also constantly looking to save costs and lift profit via the kind of technology that Pro Medicus provides.

Recently the business secured an $11 million deal over a five-year period with a private US healthcare operator in what is the world's largest private healthcare market.

Outlook

Unsurprisingly, the stock has tripled in value over the past year and the company now has a contracted revenue stream of more than $50 million over the next five years.

Based on recent share prices, Pro Medicus is now valued around $330 million with great expectations for further growth built into the price, which means any buyer at today's prices would need to be especially bullish on the company's outlook.

However, it remains that Pro Medicus has huge global healthcare markets to grow into with several tailwinds – the sky could really be the limit for this junior healthcare business.

Others operating in the healthcare and technology space worth a look include Somnomed Limited (ASX: SOM) and Primary Health Care Limited (ASX: PRY).

Although if you're looking for some red hot income stocks it might be worth reading on below…

Motley Fool contributor Tom Richardson has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »